FRONT PHARMACOL 润色咨询

Frontiers in Pharmacology

出版年份:暂无数据 年文章数:13176 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2024-03-29 ms9000001167432155 来自宁夏

    请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2022-12-10 ms3000000979708654 来自江苏省

    两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2023-04-19 卡球球 zhao 来自广东省

    请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?
    Instructions for data sharing on Jianguoyun/Nutstore
    - Enter your Sync folder and create a folder entitled "Raw Data"
    - Upload all raw data and image files to this folder
    - Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file
    - Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially.

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2024-01-14 ms3000001867061317 来自山东省

    请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀

    10

    展开10条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2024-01-14 ms3000001867061317 来自山东省

    请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2023-12-24 12099d61m86(暂无昵称) 来自重庆

    审稿速度:2.0 | 投稿命中率:95.0
    经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。
    22 Dec 2023
    Article accepted for publication.
    Review of Review Editor 1 finalized.
    19 Dec 2023
    You posted new comments.
    Submitting Author re-submitted manuscript.
    You posted new comments.
    Submitting Author posted new comments in the Editor tab.
    12 Dec 2023
    Interactive review forum activated automatically.
    06 Dec 2023
    Review of Reviewer 2 is finalized.
    20 Nov 2023
    Submitting Author submitted manuscript.

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2023-12-18 ms6000000645412256 来自四川省

    偏重的研究方向:民族药理学
    经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2023-12-17 Anlan0924 来自江苏省

    偏重的研究方向:中药药理;中药复方
    经验分享:这个杂志要不要求wb条带整膜?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2023-12-16 145f93d9m65暂无昵称 来自山东省

    meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2196014, encodeId=2962219601468, content=请问用Endnote增加网页作为参考文献,怎么修改格式啊,谢谢!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10398581904, createdName=ms9000001167432155, createdTime=Fri Mar 29 09:40:23 CST 2024, time=2024-03-29, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2105186, encodeId=b33921051868c, content=两个审稿人,修改后,一个同意,一个拒绝,最后的结局会如何?有没有这样子经历的战友?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Sat Dec 10 09:10:33 CST 2022, time=2022-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬,原始数据太大怎么上传?坚果云没用过不大会,生成的共享链接放在哪里呀?<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181567, encodeId=3ab4218156e26, content=请问投稿后收到拒稿理由是:Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是为什么呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:14:08 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2181568, encodeId=9ba121815686d, content=请问为什么会这样啊(´・Д・)」Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705f8475329, createdName=ms3000001867061317, createdTime=Sun Jan 14 16:16:57 CST 2024, time=2024-01-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:Original article. 非常愉快的一次投稿,历时一个月多几天。分享下经验。要毕业的小朋友值得投。<br>22 Dec 2023 <br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>19 Dec 2023 <br>You posted new comments.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>12 Dec 2023 <br>Interactive review forum activated automatically.<br>06 Dec 2023 <br>Review of Reviewer 2 is finalized.<br>20 Nov 2023 <br>Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向:民族药理学<br>经验分享:家人们,请问review finalized 要等多久才能accept呀,真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向:中药药理;中药复方<br>经验分享:这个杂志要不要求wb条带整膜?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析,三个审稿人,两个人接受一个拒稿,最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省)]
    2023-12-04 ms5000001006994240 来自山东省

    各位大神们,请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊?

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分